Low BCL7A expression predicts poor prognosis in ovarian cancer
Abstract Background and objective Ovarian cancer is a common gynaecological cancer with a poor prognosis that poses a serious threat to human life and health. It is essential to explore the possible prognostic biomarkers of ovarian cancer. As an important tumour suppressor gene, BCL7A actively parti...
Main Authors: | Ziqian Sun, Liang Sun, Miao He, Ying Pang, Zhaoying Yang, Junrong Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-05-01
|
Series: | Journal of Ovarian Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13048-019-0518-0 |
Similar Items
-
BCL7A as a novel prognostic biomarker for glioma patients
by: Junhui Liu, et al.
Published: (2021-08-01) -
A Pan-Cancer Analysis of the Oncogenic Role of BCL7B: A Potential Biomarker for Prognosis and Immunotherapy
by: Dinglong Yang, et al.
Published: (2022-07-01) -
LINC00152 Promotes Tumor Progression and Predicts Poor Prognosis by Stabilizing BCL6 From Degradation in the Epithelial Ovarian Cancer
by: Shunni Wang, et al.
Published: (2020-11-01) -
B7-H3 Induces Ovarian Cancer Drugs Resistance Through An PI3K/AKT/BCL-2 Signaling Pathway
by: Zhou L, et al.
Published: (2019-12-01) -
Down-regulation of BCL2L13 renders poor prognosis in clear cell and papillary renal cell carcinoma
by: Fei Meng, et al.
Published: (2021-06-01)